Cells (2020) 9(7):1642
This Isn't Really About BPC-157: The Bigger Picture of the FDA's Meeting on Peptides By Oliver Catlin , President, Banned Substances Control Group (BSCG) If you've been following the FDA's upcoming discussion on unapproved peptides, you've probably seen the conversation revolve around familiar names like BPC-157, TB-500, KPV, and MOTS-c
Measurements, progress photos, strength numbers, and how clothing fits provide better feedback than the scale, which may remain relatively stable while significant fat-to-muscle ratio improvements occur
The choice between tablets and injections often depends on personal preference and medical advice
Second, we identify many topics and groups focused on medication side effects
10.1007/978-3-319-42139-1_1 36 Eze-StevenP